What Is Psychedelic Experience?
Psychedelic Experience October 26, 2023 DOI: 10.1093/oso/9780198843757.003.0002 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Theoretical or philosophical paper Peer reviewed |
|---|---|
| Key points | Argues that the concept of a psychedelic experience, as introduced by Huxley and Osmond, is an empirical hypothesis that requires precise explication before it can be tested. |
Abstract
Abstract This chapter introduces the book's central question: what is a psychedelic experience? Upon reviewing the exchanges between Aldous Huxley and Humphry Osmond concerning their introduction of the term 'psychedelic', the chapter proposes that we should understand the notion along the lines they intended. Their idea was that substances such as psilocybin and LSD induce experiences that reveal hidden parts or aspects of the mind and, therefore, should be called “psychedelics” or mind-revealers. This was a novel and profound insight into the nature of these substances. However, it is also an empirical hypothesis that may be false and, therefore, should be tested. The chapter argues that in order to do this, we first need to explicate the concept of psychedelic experience in more precise terms so that we can know what kind of evidence may be marshalled in support of – or against – the hypothesis.
Citations in the library
Cites 243
- The benefits of being present: Mindfulness and its role in psychological well-being. Journal of Personality and Social Psychology 2003
- On a confusion about a function of consciousness Behavioral and Brain Sciences June 1, 1995
- Psilocybin produces substantial and sustained decreases in depression and anxiety in patients with life-threatening cancer: A randomized double-blind trial Journal of Psychopharmacology November 30, 2016
- Experience sampling during fMRI reveals default network and executive system contributions to mind wandering. Proceedings of the National Academy of Sciences May 26, 2009
- Rapid and sustained symptom reduction following psilocybin treatment for anxiety and depression in patients with life-threatening cancer: a randomized controlled trial Journal of Psychopharmacology November 30, 2016
and 238 more in the library